Z-2292-2025 Class II Ongoing

Recalled by Trinity Biotech USA — Jamestown, NY

FDA device recall Z-2292-2025 was initiated by Trinity Biotech USA on Jul 22, 2025 and is designated Class II. Reason for recall: Potential for Bartels ELISA Legionella Urinary Antigen kit B1029-440 lot 065 and 066 to contain particulate matter. The recall status is ongoing. Affected quantity: 968 kits.

Recall details

Product Type
Devices
Report Date
Aug 20, 2025
Initiation Date
Jul 22, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
968 kits

Product description

Bartels ELISA Legionella Urinary Antigen. Model Number: B1029-440. In Vitro Diagnostic test kit for the presumptive diagnosis of past or current Legionnaires Disease.

Reason for recall

Potential for Bartels ELISA Legionella Urinary Antigen kit B1029-440 lot 065 and 066 to contain particulate matter.

Distribution pattern

Worldwide - US Nationwide distribution in the states of Maryland and Utah. The countries of France, Germany, Ireland, Israel, Kuwait, Latvia, UK.

Code information

Model Number: B1029-440. UDI-DI: 05391516744065. Lot Numbers: 065 and 066

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2292-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2292-2025. Report a data issue: hello@regdatalab.com.